191 related articles for article (PubMed ID: 22413862)
1. Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons.
Lejeune FX; Mesrob L; Parmentier F; Bicep C; Vazquez-Manrique RP; Parker JA; Vert JP; Tourette C; Neri C
BMC Genomics; 2012 Mar; 13():91. PubMed ID: 22413862
[TBL] [Abstract][Full Text] [Related]
2. Large-scale RNA interference screening in mammalian cells identifies novel regulators of mutant huntingtin aggregation.
Yamanaka T; Wong HK; Tosaki A; Bauer PO; Wada K; Kurosawa M; Shimogori T; Hattori N; Nukina N
PLoS One; 2014; 9(4):e93891. PubMed ID: 24705917
[TBL] [Abstract][Full Text] [Related]
3. Huntingtin polyQ Mutation Impairs the 17β-Estradiol/Neuroglobin Pathway Devoted to Neuron Survival.
Nuzzo MT; Fiocchetti M; Totta P; Melone MAB; Cardinale A; Fusco FR; Gustincich S; Persichetti F; Ascenzi P; Marino M
Mol Neurobiol; 2017 Oct; 54(8):6634-6646. PubMed ID: 27957684
[TBL] [Abstract][Full Text] [Related]
4. N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy.
Liu X; Wang CE; Hong Y; Zhao T; Wang G; Gaertig MA; Sun M; Li S; Li XJ
PLoS Genet; 2016 May; 12(5):e1006083. PubMed ID: 27203582
[TBL] [Abstract][Full Text] [Related]
5. A genome-scale RNA-interference screen identifies RRAS signaling as a pathologic feature of Huntington's disease.
Miller JP; Yates BE; Al-Ramahi I; Berman AE; Sanhueza M; Kim E; de Haro M; DeGiacomo F; Torcassi C; Holcomb J; Gafni J; Mooney SD; Botas J; Ellerby LM; Hughes RE
PLoS Genet; 2012; 8(11):e1003042. PubMed ID: 23209424
[TBL] [Abstract][Full Text] [Related]
6. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
[TBL] [Abstract][Full Text] [Related]
7. A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure.
Poirier MA; Jiang H; Ross CA
Hum Mol Genet; 2005 Mar; 14(6):765-74. PubMed ID: 15689354
[TBL] [Abstract][Full Text] [Related]
8. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
[TBL] [Abstract][Full Text] [Related]
9. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
[TBL] [Abstract][Full Text] [Related]
10. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
Bates EA; Victor M; Jones AK; Shi Y; Hart AC
J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
[TBL] [Abstract][Full Text] [Related]
11. Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death.
Parker JA; Connolly JB; Wellington C; Hayden M; Dausset J; Neri C
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13318-23. PubMed ID: 11687635
[TBL] [Abstract][Full Text] [Related]
12. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
13. In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons.
Thomas EA; Coppola G; Tang B; Kuhn A; Kim S; Geschwind DH; Brown TB; Luthi-Carter R; Ehrlich ME
Hum Mol Genet; 2011 Mar; 20(6):1049-60. PubMed ID: 21177255
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
[TBL] [Abstract][Full Text] [Related]
15. Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.
Miller J; Arrasate M; Shaby BA; Mitra S; Masliah E; Finkbeiner S
J Neurosci; 2010 Aug; 30(31):10541-50. PubMed ID: 20685997
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
[TBL] [Abstract][Full Text] [Related]
17. The stress response factor daf-16/FOXO is required for multiple compound families to prolong the function of neurons with Huntington's disease.
Farina F; Lambert E; Commeau L; Lejeune FX; Roudier N; Fonte C; Parker JA; Boddaert J; Verny M; Baulieu EE; Neri C
Sci Rep; 2017 Jun; 7(1):4014. PubMed ID: 28638078
[TBL] [Abstract][Full Text] [Related]
18. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
19. The dopaminergic stabilizer, (-)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins.
Ruiz C; Casarejos MJ; Rubio I; Gines S; Puigdellivol M; Alberch J; Mena MA; de Yebenes JG
Brain Res; 2012 Jun; 1459():100-12. PubMed ID: 22560595
[TBL] [Abstract][Full Text] [Related]
20. A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila.
Zhang S; Binari R; Zhou R; Perrimon N
Genetics; 2010 Apr; 184(4):1165-79. PubMed ID: 20100940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
